Full-Time
Posted on 9/19/2025
Medical and cosmetic dermatology services
No salary listed
Lyndhurst, NJ, USA
Hybrid
Job posting mentions opportunities across multiple states and flexible placement; but the specific location provided is Nutley, NJ. No explicit remote option stated; hybrid not indicated. Treat as on-site in Nutley, NJ. Travel requirements HYBRID corresponds to mixed on-site and remote or explicit <4 in-office days; none given. But since there is multiple states and flexible placement, but the job location data is Nutley NJ per provided Locations. We'll set HYBRID? The rule: travel_requirements: HYBRID if mix or explicit <4 days. Not explicit. If no remote information provided, set remote false. Since Nutley on-site, and no remote clause, HYBRID vs IN_PERSON? It's in-person. So travel_requirements IN_PERSON. Let's set IN_PERSON and remote false. Additional_location_info: maybe mention multiple states and flexible placement, but not strictly location. We'll set as null or describe? Instruction 6 says use additional_location_info for info not strictly about location such as number of in-office days for hybrid. Here none. We can set a note about opportunities across multiple states; but that is not strictly location info? It is guidance. We'll set additional_location_info:
Schweiger Dermatology Group provides medical and cosmetic dermatology services to a wide patient base. It treats conditions like acne and skin cancer, performs mole removal, and offers cosmetic procedures such as laser treatments, Botox, and hair restoration. The company runs in-person visits and telemedicine appointments, with same-day access to care to improve convenience. Treatments are delivered by dermatology clinicians during visits or virtual consultations, and safety protocols are emphasized, especially during the COVID-19 era. Compared with competitors, Schweiger Dermatology stresses a patient-centric model with broad service offerings, quick access, and multiple care formats (in-office and telemedicine). Its goal is to make dermatology care safe, accessible, and comprehensive for routine skin care and specialized medical treatments.
Company Size
1,001-5,000
Company Stage
Growth Equity (Venture Capital)
Total Funding
$177.7M
Headquarters
New York City, New York
Founded
2010
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Flexible Work Hours
Obagi Medical, part of Waldencast plc, has partnered with Schweiger Dermatology for its ALOHA Programme to generate real-world evidence for Obagi saypha MagIQ injectable. Schweiger was selected for its clinical excellence and extensive national network. The collaboration includes two initiatives: a Phase 4 clinical study led by Dr David Goldberg in Hackensack, and a real-world evaluation programme across select Schweiger aesthetic locations. Programme activities are expected to begin in early 2026. Schweiger will present initial findings at internal leadership meetings and industry conferences. Dr Goldberg noted the partnership aligns with Schweiger's focus on accessible, high-quality care, whilst Drew Fine, Obagi's US General Manager, emphasised the company's commitment to launching the injectable with robust clinical evidence.
NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Schweiger Dermatology Group, a leading provider of dermatology and allergy care, is proud to announce it has been awarded eight Accolades by Castle Connolly. Accolades recognize health systems, hospitals and physician practices that deliver exceptional healthcare through their highly esteemed Castle Connolly Top Doctor physicians.Schweiger Dermatology Group received the following Castle Connolly Accolades for 2025:#1 for Dermatology in New York#1 for Dermatology in New York City#1 for Dermatology in Pennsylvania#1 for Dermatology in Philadelphia#1 for Dermatology in New Jersey#3 for Dermatology in Florida#2 Nationally in Dermatology#2 Nationally in Cosmetic and Reconstructive CareIn addition, 61 Schweiger Dermatology Group physicians have been recognized as Castle Connolly Top Doctors for 2025. This prestigious honor highlights the exceptional expertise and dedication of medical professionals across a growing number of specialties and locations nationwide. Castle Connolly is renowned for its rigorous selection process for Top Doctors, which involves peer nominations, research and a thorough vetting process by a physician-led research team."We are dedicated to delivering the highest level of care and innovation in dermatology and allergy," said Dr. Eric Schweiger, founder and CEO of Schweiger Dermatology Group
DSA was part of the NavaDerm platform formed in 2018.
FORT LAUDERDALE, Fla. and NEW YORK, Nov. 15, 2024 /PRNewswire/ -- NavaDerm Partners, LLC ("NavaDerm" or the "Company"), a dermatology platform and portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), announced the exit of Dermatology and Surgery Associates ("DSA") to Schweiger Dermatology Group ("SDG"). DSA was part of the NavaDerm platform formed in 2018. Vera Abramova, Chief Financial Officer of NavaDerm Partners, LLC said, "We are pleased to announce this is the third practice sold to SDG in the past year. Our remaining flagship practices - Laser Skin Surgery of New York with locations at 34th Street (NYC) and Southampton and our growing Spring Street practice with NYC locations in SoHo and Uptown, continue to benefit from the tailwinds in cosmetic dermatology."
Schweiger Dermatology Group has expanded in Florida by acquiring ClearlyDerm, a leading dermatology practice founded by Dr. Andrea Colton. This acquisition adds five new offices in South Florida, located in Boca Raton, West Boca Raton, Fort Lauderdale, Boynton Beach, and Delray Beach. Dr. Colton and her team, known for their patient-first philosophy, will join Schweiger Dermatology Group, enhancing their presence and services in the region.